Hilary M. Collins

2.5k citations

36 papers · 2.0k indexed · h-index 22

Cancer Research top 2%
- Protease and Inhibitor Mechanisms 8
Oncology top 5%
- Peptidase Inhibition and Analysis 5
Molecular Biology top 10%
- RNA Interference and Gene Delivery 7
- Ubiquitin and proteasome pathways 7
- Cancer-related gene regulation 4
- Protein Degradation and Inhibitors 4
- Retinoids in leukemia and cellular processes 3
Hematology top 5%
Immunology and Allergy top 10%
Biomaterials
- Nanoparticle-Based Drug Delivery 3

Co-authors: R. Steele Susan A. Watson Simon L. Parsons Peter de Nully Brown David M. Heery S A Watson Karin B. Kindle Magdy K. Abdelghany
Cited by: Cancer Research Oncology Molecular Biology
Journals: Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (2 papers)Journal of Biological Chemistry (1 paper)
Partner nations: United Kingdom Malaysia Egypt

In The Last Decade

Hilary M. Collins

35 papers receiving 1.9k citations

Peers

Countries citing papers authored by Hilary M. Collins

Since Specialization

Citations

This map shows the geographic impact of Hilary M. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hilary M. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hilary M. Collins more than expected).

Fields of papers citing papers by Hilary M. Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hilary M. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hilary M. Collins. The network helps show where Hilary M. Collins may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hilary M. Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hilary M. Collins Line = papers co-authored together Hilary M. Collins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Conofolidine: A Natural Plant Alkaloid That Causes Apoptosis and Senescence in Cancer Cells Molecules ·Mohammed Z.K. Al-Hayali,Choy-Eng Nge,Kuan‐Hon Lim,Hilary M. Collins,Toh‐Seok Kam,Tracey D. Bradshaw	2024	3
2	Cardiac glycoside cerberin exerts anticancer activity through PI3K/AKT/mTOR signal transduction inhibition Cancer Letters ·Md Shahadat Hossan,Zi-Yang Chan,Hilary M. Collins,Fiona Natalia Shipton,Mark S. Butler,Mohammed Rahmatullah,Jong Bong Lee,Pavel Gershkovich,Leonid Kagan,Teng-Jin Khoo,Christophe Wiart,Tracey D. Bradshaw	2019	39
3	Mechanistic insight into heterogeneity of trans-plasma membrane electron transport in cancer cell types Biochimica et Biophysica Acta (BBA) - Bioenergetics ·Harry G. Sherman,Carolyn Jovanovic,Alaa Abuawad,Dong‐Hyun Kim,Hilary M. Collins,James E. Dixon,Robert Cavanagh,Róbert Márkus,Snow Stolnik,Frankie J. Rawson	2019	13
4	Sustainable Syntheses of (−)-Jerantinines A & E and Structural Characterisation of the Jerantinine-Tubulin Complex at the Colchicine Binding Site Scientific Reports ·Christopher J. Smedley,Paul A. Stanley,Mohannad E. Qazzaz,A.E. Prota,Natacha Olieric,Hilary M. Collins,Harry Eastman,Andrew S. Barrow,Kuan‐Hon Lim,Toh‐Seok Kam,Brian J. Smith,Hendrika M. Duivenvoorden,Belinda S. Parker,Tracey D. Bradshaw,Michel O. Steinmetz,John E. Moses	2018	11
5	Discovery of a highly active anticancer analogue of cardamonin that acts as an inducer of caspase-dependent apoptosis and modulator of the mTOR pathway Fitoterapia ·Mohammed Khaled Bin Break,Md Shahadat Hossan,Yivonn Khoo,Mohannad E. Qazzaz,Mohammed Z.K. Al-Hayali,Sek C. Chow,Christophe Wiart,Tracey D. Bradshaw,Hilary M. Collins,Teng-Jin Khoo	2018	28
6	Heterodimers of photoreceptor-specific nuclear receptor (PNR/NR2E3) and peroxisome proliferator-activated receptor-γ (PPARγ) are disrupted by retinal disease-associated mutations Cell Death and Disease ·Joel Fulton,Bismoy Mazumder,Jonathan B. Whitchurch,Cíntia J. Monteiro,Hilary M. Collins,Chun Ming Chan,Maria P Clemente,Miguel Hernández-Quiles,Elizabeth A. Stewart,Winfried M. K. Amoaku,Paula M. Moran,Nigel P. Mongan,Jenny L. Persson,Simak Ali,David M. Heery	2017	7
7	The double PHD finger domain of MOZ/MYST3 induces α-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification Nucleic Acids Research ·Ingrid Dreveny,S.E. Deeves,Joel Fulton,Baigong Yue,Marie C. Messmer,Amit Bhattacharya,Hilary M. Collins,David M. Heery	2013	64
8	Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells BMC Cancer ·Hilary M. Collins,Magdy K. Abdelghany,Marie C. Messmer,Baigong Yue,S.E. Deeves,Karin B. Kindle,Kempegowda Mantelingu,Akhmed Aslam,G. Sebastiaan Winkler,Tapas K. Kundu,David M. Heery	2013	79
9	A signature motif mediating selective interactions of BCL11A with the NR2E/F subfamily of orphan nuclear receptors Nucleic Acids Research ·Chun Ming Chan,Joel Fulton,Cristina Montiel‐Duarte,Hilary M. Collins,Neetu Bharti,Frances Wadelin,Paula M. Moran,Nigel P. Mongan,David M. Heery	2013	18
10	PRAME Is a Golgi-Targeted Protein That Associates with the Elongin BC Complex and Is Upregulated by Interferon-Gamma and Bacterial PAMPs PLoS ONE ·Frances Wadelin,Joel Fulton,Hilary M. Collins,Nikolaos Tertipis,Andrew Bottley,Keith A. Spriggs,Franco H. Falcone,David M. Heery	2013	23
11	Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome Cancer Research ·Somaia Elsheikh,Andrew R. Green,Emad A. Rakha,Des G. Powe,Rabab A. Ahmed,Hilary M. Collins,Daniele Soria,Jonathan M. Garibaldi,Claire E. Paish,Amr Ammar,Matthew J. Grainge,Graham Ball,Magdy K. Abdelghany,Luisa Martı́nez-Pomares,David M. Heery,Ian O. Ellis	2009	366
12	MOZ-TIF2 Alters Cofactor Recruitment and Histone Modification at the RARβ2 Promoter Journal of Biological Chemistry ·Hilary M. Collins,Karin B. Kindle,Sachiko Matsuda,Colm M. Ryan,Philip J.F. Troke,Eric Kalkhoven,David M. Heery	2006	25
13	Functional Interaction of CREB Binding Protein (CBP) with Nuclear Transport Proteins and Modulation by HDAC Inhibitors Cell Cycle ·Colm M. Ryan,Janet C. Harries,Karin B. Kindle,Hilary M. Collins,David M. Heery	2006	24
14	Effect of preoperative radiotherapy on matrilysin gene expression in rectal cancer European Journal of Cancer ·Arun Kumar,Hilary M. Collins,Janet Tam,J H Scholefield,S A Watson	2002	24
15	Matrix metalloproteinases 2 and 9 in otitis media with effusion Clinical Otolaryngology ·C. R. Jennings,Long Guo,Hilary M. Collins,John P. Birchall	2001	14
16	Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-1-matrix metalloproteinase British Journal of Cancer ·Hilary M. Collins,Teresa Morris,S A Watson	2001	52
17	Increased type-IV collagenase (MMP-2 and MMP-9) activity following preoperative radiotherapy in rectal cancer British Journal of Cancer ·Arun Kumar,Hilary M. Collins,J H Scholefield,S A Watson	2000	43
18	Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA British Journal of Cancer ·Sue‐Ann Watson,Teresa Morris,Hilary M. Collins,Lindsay J. Bawden,Kim Hawkins,Elisabeth A. Bone	1999	47
19	The analysis of middle ear effusion for matrix metalloproteinases 2 and 9 Clinical Otolaryngology ·C. R. Jennings,Hilary M. Collins,Li He GUO,John P. Birchall	1999	1
20	Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy British Journal of Cancer ·SL Parsons,SA Watson,Hilary M. Collins,NR Griffin,Philip A. Clarke,R. Steele	1998	112

About Hilary M. Collins

Hilary M. Collins is a scholar working on Cancer Research, Otorhinolaryngology and Oncology, having authored 36 papers that have together received 2.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (8 papers), RNA Interference and Gene Delivery (7 papers), Ubiquitin and proteasome pathways (7 papers), Peptidase Inhibition and Analysis (5 papers), Cancer-related gene regulation (4 papers), Protein Degradation and Inhibitors (4 papers), Nanoparticle-Based Drug Delivery (3 papers) and Retinoids in leukemia and cellular processes (3 papers). The work is most often cited by research in Cancer Research (667 citations), Oncology (546 citations) and Molecular Biology (1.1k citations). Hilary M. Collins has collaborated with scholars based in United Kingdom, Malaysia and Egypt. Frequent co-authors include R. Steele, Susan A. Watson, Simon L. Parsons, Peter de Nully Brown, David M. Heery, S A Watson, Karin B. Kindle, Magdy K. Abdelghany, Teresa Morris and Tracey D. Bradshaw. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact